Wells Fargo Raises its Price Target on The Clorox Company (CLX) to $125 and Maintains an Equal Weight Rating

Jeff Lewis

Sun, February 22, 2026 at 8:37 AM GMT+9 2 min read

In this article:

CLX

+1.13%

^GSPC

+0.69%

The Clorox Company (NYSE:CLX) is among the 11 Best High Growth Consumer Stocks to Buy Right Now.

Wells Fargo Raises its Price Target on The Clorox Company (CLX) to $125 and Maintains an Equal Weight Rating

On February 17, 2026, Wells Fargo analyst Chris Carey raised the price target on The Clorox Company (NYSE:CLX) to $125 from $115 and maintained an Equal Weight rating. Chris Carey noted this marks the best start for Staples versus the S&P 500 on record and said Wells Fargo is refreshing price targets to reflect sector moves.

On February 13, 2026, Rothschild & Co Redburn raised the price target to $117 from $115 and kept a Neutral rating, stating that after a challenging 2025, the home and personal care sector has gained 14% in 2026, and category growth rates appear to be stabilizing. On February 4, 2026, BofA analyst Anna Lizzul raised the price target to $112 from $110 and maintained a Neutral rating after fiscal Q2 adjusted EPS came in below BofA’s estimate due to gross margin pressure from higher costs. Anna Lizzul maintained “more tepid forecasts” for the second half, citing uncertainty around improvements in consumption and margins.

On February 3, 2026, Clorox reported Q2 revenue of $1.67B, above consensus of $1.64B. Chair and CEO Linda Rendle said results were “generally in line with our expectations” and reflect continued progress against strategic priorities, supporting the company’s ability to reaffirm its fiscal year outlook despite a challenging environment. Linda Rendle added that Clorox remains focused on executing second-half plans, advancing its transformation, and expanding its leadership position in health and hygiene through the recently announced acquisition of GOJO Industries.

The Clorox Company (NYSE:CLX) manufactures and markets consumer and professional products worldwide across Health and Wellness, Household, Lifestyle, and International segments.

While we acknowledge the potential of CLX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Most Profitable Undervalued Stocks to Buy and 11 Best Mining Stocks to Buy According to Wall Street.

Disclosure: None.

條款 及 私隱政策

Privacy Dashboard

More Info